Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$1.09M
4 trades · 1 insiders
Net · 90d
$-1.09M
Insiders on file
29
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Robertson Stephen P. | EVP, General Counsel | 25 | $14.5K | $2.74M | 2026-09-10 |
| Goetz Kathleen | Director | 2 | $0 | $0 | 2026-06-04 |
| Bailey Jeffrey Allen | Director | 10 | $0 | $38.4K | 2026-06-04 |
| Johnson Craig A | Director | 5 | $0 | $0 | 2026-06-04 |
| Nova Tina Susan | Director | 2 | $0 | $0 | 2026-06-04 |
| TANG KEVIN | Director | 24 | $62.27M | $0 | 2026-06-02 |
| Cole Ryan | Chief Operating Officer | 2 | $0 | $0 | 2026-05-18 |
| Hearne Michael S | Chief Financial Officer | 2 | $0 | $0 | 2026-05-18 |
| Keenan Greg | SVP, Chief Medical Officer | 9 | $0 | $376.3K | 2026-03-06 |
| Miller Joseph M | Chief Financial Officer | 21 | $9.7K | $1.37M | 2026-03-02 |
| Donley Matthew Maxwell | Ex VP, Internal Operations | 20 | $146.3K | $1.26M | 2026-03-02 |
| Greenleaf Peter | Chief Executive Officer | 22 | $54.9K | $4.27M | 2026-03-02 |
| Jayne David R.W. | Director | 13 | $0 | $126.7K | 2024-11-21 |
| Leversage Jill | Director | 15 | $85.1K | $86.4K | 2024-11-21 |
| Smith Karen L. | Director | 7 | $0 | $44.2K | 2024-11-21 |
| Habig Scott Michael | Chief Commercial Officer | 8 | $25.1K | $283.4K | 2024-08-06 |
| Balakrishnan Brinda | Director | 8 | $0 | $3.0K | 2024-05-21 |
| MacKay-Dunn R. Hector | Director | 14 | $105.5K | $86.6K | 2024-05-21 |
| Billen Daniel | Director | 9 | $0 | $82.5K | 2024-05-21 |
| Knappertz Volker | EVP, Research and Development | 5 | $0 | $167.9K | 2024-02-27 |
| Foster Robert T | Director | 2 | $0 | $0 | 2023-09-21 |
| Hagan Joseph P | Director | 10 | $0 | $906.5K | 2023-05-19 |
| MILNE GEORGE M JR | Director | 8 | $297.3K | $0 | 2023-05-18 |
| Martin Michael Robert | Chief Business Officer | 46 | $154.8K | $12.85M | 2023-03-02 |
| Walbert Timothy P | Director | 3 | $0 | $0 | 2022-05-18 |
| Solomons Neil | Chief Medical Officer | 25 | $0 | $13.31M | 2022-03-02 |
| Huizinga Robert Bindert | Ex Vice President of Research | 19 | $0 | $5.48M | 2022-03-02 |
| Colao Massimilano | Chief Commercial Officer | 4 | $0 | $38.5K | 2022-03-02 |
| Hayden Michael R | Director | 6 | $0 | $0 | 2021-01-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Robertson Stephen P. | Chief Legal Officer | S Sale | 2026-09-10 | 2026-09-11 | 11,939 | $15.95 | $190.4K | 588,848 | SEC↗ |
| Robertson Stephen P. | Chief Legal Officer | S Sale | 2026-09-10 | 2026-09-11 | 11,939 | $15.95 | $190.4K | 588,848 | SEC↗ |
| Robertson Stephen P. | Chief Legal Officer | S Sale | 2026-08-21 | 2026-08-25 | 20,975 | $16.97 | $355.9K | 600,787 | SEC↗ |
| Robertson Stephen P. | Chief Legal Officer | S Sale | 2026-08-21 | 2026-08-25 | 20,975 | $16.97 | $355.9K | 600,787 | SEC↗ |
| Bailey Jeffrey Allen | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 23,931 | — | $0 | 23,931 | SEC↗ |
| Nova Tina Susan | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 23,931 | — | $0 | 23,931 | SEC↗ |
| Goetz Kathleen | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 23,931 | — | $0 | 23,931 | SEC↗ |
| Johnson Craig A | Director | A Award deriv | 2026-06-04 | 2026-06-08 | 23,931 | — | $0 | 23,931 | SEC↗ |
| TANG KEVIN | Chief Executive Officer | J Other deriv | 2026-06-02 | 2026-06-02 | 10,000 | $1.65 | $16.5K | 10,000 | SEC↗ |
| TANG KEVIN | Chief Executive Officer | P Buy | 2026-06-02 | 2026-06-02 | 206,005 | $15.28 | $3.15M | 13,044,106 | SEC↗ |
| TANG KEVIN | Chief Executive Officer | P Buy | 2026-06-01 | 2026-06-02 | 99 | $15.34 | $1.5K | 12,838,101 | SEC↗ |
| TANG KEVIN | Chief Executive Officer | P Buy | 2026-06-01 | 2026-06-02 | 343,521 | $15.28 | $5.25M | 12,838,002 | SEC↗ |
| TANG KEVIN | Chief Executive Officer | P Buy | 2026-05-29 | 2026-06-02 | 262,682 | $15.31 | $4.02M | 12,494,481 | SEC↗ |
| TANG KEVIN | Chief Executive Officer | P Buy | 2026-05-29 | 2026-06-02 | 2,299 | $15.35 | $35.3K | 12,231,799 | SEC↗ |
| Cole Ryan | Chief Operating Officer | A Award deriv | 2026-05-18 | 2026-05-20 | 70,230 | — | $0 | 70,230 | SEC↗ |
| Hearne Michael S | Chief Financial Officer | A Award deriv | 2026-05-18 | 2026-05-20 | 70,230 | — | $0 | 70,230 | SEC↗ |
| Cole Ryan | Chief Operating Officer | A Award | 2026-05-18 | 2026-05-20 | 116,144 | — | $0 | 116,144 | SEC↗ |
| Hearne Michael S | Chief Financial Officer | A Award | 2026-05-18 | 2026-05-20 | 116,144 | — | $0 | 116,144 | SEC↗ |
| Robertson Stephen P. | Chief Legal Officer | A Award | 2026-05-18 | 2026-05-20 | 115,541 | — | $0 | 621,402 | SEC↗ |
| Keenan Greg | SVP, Chief Medical Officer | F Tax w/h | 2026-03-06 | 2026-03-10 | 8,069 | $14.32 | $115.5K | 154,449 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2026-03-03 | 2026-03-03 | 184,208 | $14.22 | $2.62M | 12,229,500 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | F Tax w/h | 2026-03-02 | 2026-03-03 | 36,525 | $14.21 | $519.0K | 505,861 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | F Tax w/h | 2026-03-02 | 2026-03-03 | 100,890 | $14.21 | $1.43M | 1,840,379 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | F Tax w/h | 2026-03-02 | 2026-03-03 | 40,761 | $14.21 | $579.2K | 680,299 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | F Tax w/h | 2026-03-02 | 2026-03-03 | 37,511 | $14.21 | $533.0K | 576,421 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2026-03-02 | 2026-03-03 | 115,792 | $14.21 | $1.65M | 12,045,292 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2026-03-02 | 2026-03-03 | 83,561 | $14.33 | $1.20M | 11,929,500 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award deriv | 2026-02-27 | 2026-03-03 | 98,813 | — | $0 | 98,813 | SEC↗ |
| Keenan Greg | SVP, Chief Medical Officer | A Award deriv | 2026-02-27 | 2026-03-03 | 67,870 | — | $0 | 67,870 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award deriv | 2026-02-27 | 2026-03-03 | 328,424 | — | $0 | 328,424 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | A Award deriv | 2026-02-27 | 2026-03-03 | 97,256 | — | $0 | 97,256 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award deriv | 2026-02-27 | 2026-03-03 | 95,700 | — | $0 | 95,700 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award | 2026-02-27 | 2026-03-03 | 59,090 | — | $0 | 542,386 | SEC↗ |
| Keenan Greg | SVP, Chief Medical Officer | A Award | 2026-02-27 | 2026-03-03 | 40,586 | — | $0 | 162,518 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award | 2026-02-27 | 2026-03-03 | 196,403 | — | $0 | 1,941,269 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | A Award | 2026-02-27 | 2026-03-03 | 58,160 | — | $0 | 721,060 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award | 2026-02-27 | 2026-03-03 | 57,229 | — | $0 | 613,932 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2026-02-27 | 2026-03-03 | 300,000 | $13.90 | $4.17M | 11,629,500 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2026-02-27 | 2026-03-03 | 1,600 | $14.38 | $23.0K | 11,845,939 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2026-02-27 | 2026-03-03 | 214,839 | $14.12 | $3.03M | 11,844,339 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | F Tax w/h | 2026-02-20 | 2026-02-23 | 34,638 | $14.40 | $498.8K | 483,296 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | F Tax w/h | 2026-02-20 | 2026-02-23 | 32,424 | $14.40 | $466.9K | 556,703 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | F Tax w/h | 2026-02-20 | 2026-02-23 | 100,171 | $14.40 | $1.44M | 1,744,866 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | F Tax w/h | 2026-02-20 | 2026-02-23 | 32,901 | $14.40 | $473.8K | 662,900 | SEC↗ |
| Keenan Greg | SVP, Chief Medical Officer | F Tax w/h | 2026-02-02 | 2026-02-03 | 11,552 | $14.53 | $167.9K | 121,932 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award | 2026-01-02 | 2026-01-05 | 165,384 | — | $0 | 1,954,329 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | F Tax w/h | 2026-01-02 | 2026-01-05 | 113,169 | $15.95 | $1.81M | 1,845,037 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | F Tax w/h | 2026-01-02 | 2026-01-05 | 40,161 | $15.95 | $640.6K | 589,127 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award | 2026-01-02 | 2026-01-05 | 49,038 | — | $0 | 626,399 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | A Award | 2026-01-02 | 2026-01-05 | 54,166 | — | $0 | 734,631 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | F Tax w/h | 2026-01-02 | 2026-01-05 | 42,787 | $15.95 | $682.5K | 695,801 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | F Tax w/h | 2026-01-02 | 2026-01-05 | 40,385 | $15.95 | $644.1K | 517,934 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award | 2026-01-02 | 2026-01-05 | 48,558 | — | $0 | 557,434 | SEC↗ |
| Johnson Craig A | Director | F Tax w/h | 2025-11-21 | 2025-11-24 | 6,039 | $15.68 | $94.7K | 14,592 | SEC↗ |
| Bailey Jeffrey Allen | Director | F Tax w/h | 2025-11-21 | 2025-11-24 | 2,716 | $15.68 | $42.6K | 22,775 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2025-08-05 | 2025-08-05 | 200,000 | $11.68 | $2.34M | 11,329,500 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2025-08-04 | 2025-08-05 | 100,000 | $11.34 | $1.13M | 11,129,500 | SEC↗ |
| Keenan Greg | Chief Medical Officer | S Sale | 2025-08-01 | 2025-08-05 | 20,000 | $10.50 | $210.0K | 133,484 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2025-08-01 | 2025-08-05 | 1,000,000 | $10.12 | $10.12M | 11,029,500 | SEC↗ |
| Bailey Jeffrey Allen | Director | A Award deriv | 2025-05-16 | 2025-05-16 | 37,485 | — | $0 | 37,485 | SEC↗ |
| Goetz Kathleen | Director | A Award deriv | 2025-05-16 | 2025-05-16 | 63,724 | — | $0 | 63,724 | SEC↗ |
| Johnson Craig A | Director | A Award deriv | 2025-05-16 | 2025-05-16 | 37,485 | — | $0 | 37,485 | SEC↗ |
| Nova Tina Susan | Director | A Award deriv | 2025-05-16 | 2025-05-16 | 63,724 | — | $0 | 63,724 | SEC↗ |
| Keenan Greg | Chief Medical Officer | S Sale | 2025-03-07 | 2025-03-07 | 8,305 | $8.23 | $68.4K | 153,484 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2025-03-04 | 2025-03-04 | 148,038 | $8.00 | $1.18M | 9,429,500 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2025-03-04 | 2025-03-04 | 500,000 | $7.92 | $3.96M | 9,929,500 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2025-03-04 | 2025-03-04 | 100,000 | $8.09 | $809.0K | 10,029,500 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | S Sale | 2025-03-04 | 2025-03-04 | 58,991 | $7.92 | $467.2K | 680,465 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | S Sale | 2025-03-04 | 2025-03-04 | 57,607 | $7.92 | $456.2K | 509,276 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | S Sale | 2025-03-04 | 2025-03-04 | 56,154 | $7.92 | $444.7K | 577,361 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | S Sale | 2025-03-04 | 2025-03-04 | 164,947 | $7.92 | $1.31M | 1,788,945 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2025-03-03 | 2025-03-04 | 351,962 | $8.02 | $2.82M | 9,281,462 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2025-03-03 | 2025-03-04 | 100,720 | $7.97 | $802.7K | 8,929,500 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | A Award | 2025-03-03 | 2025-03-04 | 135,567 | — | $0 | 805,358 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | S Sale | 2025-03-03 | 2025-03-04 | 65,902 | $8.00 | $527.2K | 739,456 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award | 2025-03-03 | 2025-03-04 | 102,406 | — | $0 | 631,755 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | S Sale | 2025-03-03 | 2025-03-04 | 64,872 | $8.00 | $519.0K | 566,883 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award | 2025-03-03 | 2025-03-04 | 114,711 | — | $0 | 695,374 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | S Sale | 2025-03-03 | 2025-03-04 | 61,859 | $8.00 | $494.9K | 633,515 | SEC↗ |
| Keenan Greg | Chief Medical Officer | S Sale | 2025-03-03 | 2025-03-04 | 12,239 | $8.00 | $97.9K | 161,789 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award | 2025-03-03 | 2025-03-04 | 333,705 | — | $0 | 2,149,485 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-04 | 195,593 | $8.00 | $1.56M | 1,953,892 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | A Award deriv | 2025-02-28 | 2025-03-04 | 126,416 | — | $0 | 126,416 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award deriv | 2025-02-28 | 2025-03-04 | 128,438 | — | $0 | 128,438 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award deriv | 2025-02-28 | 2025-03-04 | 124,393 | — | $0 | 124,393 | SEC↗ |
| Keenan Greg | Chief Medical Officer | A Award deriv | 2025-02-28 | 2025-03-04 | 95,570 | — | $0 | 95,570 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award deriv | 2025-02-28 | 2025-03-04 | 443,973 | — | $0 | 443,973 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2025-02-28 | 2025-03-04 | 399,280 | $7.85 | $3.13M | 8,828,780 | SEC↗ |
| Donley Matthew Maxwell | Chief Operating Officer | A Award | 2025-02-28 | 2025-03-04 | 82,781 | — | $0 | 669,791 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award | 2025-02-28 | 2025-03-04 | 84,106 | — | $0 | 529,349 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award | 2025-02-28 | 2025-03-04 | 81,457 | — | $0 | 580,663 | SEC↗ |
| Keenan Greg | Chief Medical Officer | A Award | 2025-02-28 | 2025-03-04 | 62,583 | — | $0 | 174,028 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award | 2025-02-28 | 2025-03-04 | 290,728 | — | $0 | 1,815,780 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2024-12-09 | 2024-12-09 | 500,000 | $9.09 | $4.54M | 8,429,500 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2024-12-06 | 2024-12-09 | 400,000 | $9.01 | $3.60M | 7,929,500 | SEC↗ |
| TANG KEVIN | Director | P Buy | 2024-12-05 | 2024-12-09 | 300,000 | $8.91 | $2.67M | 7,529,500 | SEC↗ |
| Jayne David R.W. | Director | A Award deriv | 2024-11-21 | 2024-11-25 | 18,641 | — | $0 | 18,641 | SEC↗ |
| Bailey Jeffrey Allen | Director | A Award deriv | 2024-11-21 | 2024-11-25 | 18,641 | — | $0 | 18,641 | SEC↗ |
| Johnson Craig A | Director | A Award deriv | 2024-11-21 | 2024-11-25 | 31,688 | — | $0 | 31,688 | SEC↗ |
| Leversage Jill | Director | A Award deriv | 2024-11-21 | 2024-11-25 | 18,641 | — | $0 | 18,641 | SEC↗ |
| Smith Karen L. | Director | A Award deriv | 2024-11-21 | 2024-11-25 | 18,641 | — | $0 | 18,641 | SEC↗ |
| Jayne David R.W. | Director | A Award | 2024-11-21 | 2024-11-25 | 12,135 | — | $0 | 56,499 | SEC↗ |
| Bailey Jeffrey Allen | Director | A Award | 2024-11-21 | 2024-11-25 | 12,135 | — | $0 | 25,491 | SEC↗ |
| Johnson Craig A | Director | A Award | 2024-11-21 | 2024-11-25 | 20,631 | — | $0 | 20,631 | SEC↗ |
| Leversage Jill | Director | A Award | 2024-11-21 | 2024-11-25 | 12,135 | — | $0 | 25,053 | SEC↗ |
| Smith Karen L. | Director | A Award | 2024-11-21 | 2024-11-25 | 12,135 | — | $0 | 24,807 | SEC↗ |
| Smith Karen L. | Director | S Sale | 2024-11-11 | 2024-11-12 | 5,241 | $8.43 | $44.2K | 12,672 | SEC↗ |
| Bailey Jeffrey Allen | Director | S Sale | 2024-11-11 | 2024-11-12 | 4,557 | $8.43 | $38.4K | 13,356 | SEC↗ |
| Smith Karen L. | Director | M Exercise deriv | 2024-11-08 | 2024-11-12 | 17,913 | — | $0 | 0 | SEC↗ |
| Bailey Jeffrey Allen | Director | M Exercise deriv | 2024-11-08 | 2024-11-12 | 17,913 | — | $0 | 0 | SEC↗ |
| Smith Karen L. | Director | M Exercise | 2024-11-08 | 2024-11-12 | 17,913 | — | $0 | 17,913 | SEC↗ |
| Bailey Jeffrey Allen | Director | M Exercise | 2024-11-08 | 2024-11-12 | 17,913 | — | $0 | 17,913 | SEC↗ |
| Habig Scott Michael | Chief Commercial Officer | S Sale | 2024-08-06 | 2024-08-08 | 18,249 | $5.31 | $96.9K | 456,338 | SEC↗ |
| MacKay-Dunn R. Hector | Director | S Sale | 2024-05-21 | 2024-05-22 | 5,630 | $5.74 | $32.3K | 18,595 | SEC↗ |
| Leversage Jill | Director | S Sale | 2024-05-21 | 2024-05-22 | 5,610 | $5.74 | $32.2K | 12,918 | SEC↗ |
| Jayne David R.W. | Director | S Sale | 2024-05-21 | 2024-05-22 | 4,946 | $5.74 | $28.4K | 44,364 | SEC↗ |
| Billen Daniel | Director | S Sale | 2024-05-21 | 2024-05-22 | 5,252 | $5.74 | $30.1K | 28,141 | SEC↗ |
| Balakrishnan Brinda | Director | S Sale | 2024-05-21 | 2024-05-22 | 520 | $5.74 | $3.0K | 17,523 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | S Sale | 2024-03-06 | 2024-03-07 | 57,745 | $5.60 | $323.4K | 443,824 | SEC↗ |
| Habig Scott Michael | Chief Commercial Officer | S Sale | 2024-03-06 | 2024-03-07 | 17,777 | $5.60 | $99.6K | 474,587 | SEC↗ |
| Donley Matthew Maxwell | EVP, Ops & Strategy | S Sale | 2024-03-06 | 2024-03-07 | 40,665 | $5.51 | $224.1K | 584,072 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | S Sale | 2024-03-06 | 2024-03-07 | 34,811 | $5.60 | $194.9K | 495,928 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | S Sale | 2024-03-06 | 2024-03-07 | 126,981 | $5.60 | $711.1K | 1,522,114 | SEC↗ |
| Knappertz Volker | EVP, Research and Developmen | S Sale | 2024-02-27 | 2024-02-29 | 4,930 | $6.10 | $30.1K | 319,128 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award | 2024-02-20 | 2024-02-22 | 661,538 | — | $0 | 1,649,095 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award | 2024-02-20 | 2024-02-22 | 196,153 | — | $0 | 530,739 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award | 2024-02-20 | 2024-02-22 | 194,230 | — | $0 | 501,569 | SEC↗ |
| Donley Matthew Maxwell | EVP, Ops & Strategy | A Award | 2024-02-20 | 2024-02-22 | 216,666 | — | $0 | 624,737 | SEC↗ |
| Habig Scott Michael | Chief Commercial Officer | A Award | 2024-02-20 | 2024-02-22 | 195,512 | — | $0 | 508,231 | SEC↗ |
| Habig Scott Michael | Chief Commercial Officer | S Sale | 2024-02-20 | 2024-02-22 | 15,867 | $5.48 | $87.0K | 492,364 | SEC↗ |
| Knappertz Volker | EVP, Research and Developmen | S Sale | 2024-02-20 | 2024-02-22 | 25,146 | $5.48 | $137.8K | 324,058 | SEC↗ |
| Foster Robert T | Director | A Award deriv | 2023-09-21 | 2023-09-22 | 32,900 | — | $0 | 32,900 | SEC↗ |
| Foster Robert T | Director | A Award deriv | 2023-09-21 | 2023-09-22 | 20,383 | — | $0 | 20,383 | SEC↗ |
| Smith Karen L. | Director | A Award deriv | 2023-08-18 | 2023-08-21 | 17,913 | — | $0 | 17,913 | SEC↗ |
| Smith Karen L. | Director | A Award deriv | 2023-08-18 | 2023-08-21 | 28,959 | — | $0 | 28,959 | SEC↗ |
| Bailey Jeffrey Allen | Director | A Award deriv | 2023-08-18 | 2023-08-21 | 28,959 | — | $0 | 28,959 | SEC↗ |
| Bailey Jeffrey Allen | Director | A Award deriv | 2023-08-18 | 2023-08-21 | 17,913 | — | $0 | 17,913 | SEC↗ |
| Leversage Jill | Director | S Sale | 2023-05-23 | 2023-05-23 | 4,815 | $11.26 | $54.2K | 18,528 | SEC↗ |
| MacKay-Dunn R. Hector | Director | S Sale | 2023-05-23 | 2023-05-23 | 4,818 | $11.26 | $54.3K | 24,225 | SEC↗ |
| Billen Daniel | Director | S Sale | 2023-05-23 | 2023-05-23 | 4,650 | $11.26 | $52.4K | 33,393 | SEC↗ |
| Jayne David R.W. | Director | S Sale | 2023-05-23 | 2023-05-23 | 8,733 | $11.26 | $98.3K | 49,310 | SEC↗ |
| Leversage Jill | Director | A Award deriv | 2023-05-19 | 2023-05-23 | 15,234 | — | $0 | 15,234 | SEC↗ |
| MacKay-Dunn R. Hector | Director | A Award deriv | 2023-05-19 | 2023-05-23 | 15,234 | — | $0 | 15,234 | SEC↗ |
| Billen Daniel | Director | A Award deriv | 2023-05-19 | 2023-05-23 | 15,234 | — | $0 | 15,234 | SEC↗ |
| Jayne David R.W. | Director | A Award deriv | 2023-05-19 | 2023-05-23 | 15,234 | — | $0 | 15,234 | SEC↗ |
| Balakrishnan Brinda | Director | A Award deriv | 2023-05-19 | 2023-05-23 | 15,234 | — | $0 | 15,234 | SEC↗ |
| Leversage Jill | Director | A Award | 2023-05-19 | 2023-05-23 | 9,310 | — | $0 | 23,343 | SEC↗ |
| MacKay-Dunn R. Hector | Director | A Award | 2023-05-19 | 2023-05-23 | 9,310 | — | $0 | 29,043 | SEC↗ |
| Billen Daniel | Director | A Award | 2023-05-19 | 2023-05-23 | 9,310 | — | $0 | 38,043 | SEC↗ |
| Hagan Joseph P | Director | S Sale | 2023-05-19 | 2023-05-23 | 272 | $10.58 | $2.9K | 11,961 | SEC↗ |
| Jayne David R.W. | Director | A Award | 2023-05-19 | 2023-05-23 | 9,310 | — | $0 | 58,043 | SEC↗ |
| Balakrishnan Brinda | Director | A Award | 2023-05-19 | 2023-05-23 | 9,310 | — | $0 | 18,043 | SEC↗ |
| Leversage Jill | Director | M Exercise deriv | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 0 | SEC↗ |
| MacKay-Dunn R. Hector | Director | M Exercise deriv | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 0 | SEC↗ |
| MILNE GEORGE M JR | Director | M Exercise deriv | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 0 | SEC↗ |
| Billen Daniel | Director | M Exercise deriv | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 0 | SEC↗ |
| Hagan Joseph P | Director | M Exercise deriv | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 0 | SEC↗ |
| Jayne David R.W. | Director | M Exercise deriv | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 0 | SEC↗ |
| Balakrishnan Brinda | Director | M Exercise deriv | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 0 | SEC↗ |
| Leversage Jill | Director | M Exercise | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 14,033 | SEC↗ |
| MacKay-Dunn R. Hector | Director | M Exercise | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 19,733 | SEC↗ |
| MILNE GEORGE M JR | Director | M Exercise | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 78,733 | SEC↗ |
| Billen Daniel | Director | M Exercise | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 28,733 | SEC↗ |
| Hagan Joseph P | Director | M Exercise | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 12,233 | SEC↗ |
| Jayne David R.W. | Director | M Exercise | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 48,733 | SEC↗ |
| Balakrishnan Brinda | Director | M Exercise | 2023-05-18 | 2023-05-23 | 8,733 | — | $0 | 8,733 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | S Sale | 2023-03-02 | 2024-02-22 | 33,047 | $8.78 | $290.2K | 982,671 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | S Sale | 2023-03-02 | 2024-02-22 | 11,398 | $8.78 | $100.1K | 331,112 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | S Sale | 2023-03-02 | 2024-02-22 | 19,644 | $8.78 | $172.5K | 303,122 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award | 2023-03-02 | 2023-03-06 | 667,407 | — | $0 | 1,015,718 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | S Sale | 2023-03-02 | 2023-03-06 | 32,750 | $8.94 | $292.8K | 982,968 | SEC↗ |
| Knappertz Volker | EVP, Research and Developmen | A Award | 2023-03-02 | 2023-03-06 | 191,462 | — | $0 | 344,274 | SEC↗ |
| Habig Scott Michael | Chief Commercial Officer | A Award | 2023-03-02 | 2023-03-06 | 170,188 | — | $0 | 312,719 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | A Award | 2023-03-02 | 2023-03-06 | 107,202 | — | $0 | 259,162 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | S Sale | 2023-03-02 | 2023-03-06 | 19,402 | $8.94 | $173.5K | 303,364 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award | 2023-03-02 | 2023-03-06 | 204,810 | — | $0 | 322,766 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | S Sale | 2023-03-02 | 2023-03-06 | 11,296 | $8.94 | $101.0K | 331,214 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award | 2023-03-02 | 2023-03-06 | 229,421 | — | $0 | 342,510 | SEC↗ |
| Donley Matthew Maxwell | EVP, Ops & Strategy | A Award | 2023-03-02 | 2023-03-06 | 271,134 | — | $0 | 403,141 | SEC↗ |
| MILNE GEORGE M JR | Director | P Buy | 2023-03-02 | 2023-03-06 | 20,000 | $8.91 | $178.2K | 70,000 | SEC↗ |
| Donley Matthew Maxwell | Ex VP, Internal Operations | P Buy | 2022-11-21 | 2022-11-23 | 10,000 | $4.66 | $46.6K | 27,927 | SEC↗ |
| Habig Scott Michael | Chief Commercial Officer | P Buy | 2022-11-09 | 2022-11-14 | 5,000 | $5.02 | $25.1K | 5,000 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | P Buy | 2022-11-07 | 2022-11-09 | 30,000 | $5.16 | $154.8K | 89,512 | SEC↗ |
| Habig Scott Michael | Chief Commercial Officer | A Award deriv | 2022-08-01 | 2022-08-01 | 231,203 | — | $0 | 231,203 | SEC↗ |
| Habig Scott Michael | Chief Commercial Officer | A Award deriv | 2022-08-01 | 2022-08-01 | 137,531 | — | $0 | 137,531 | SEC↗ |
| Knappertz Volker | EVP, Research and Developmen | A Award deriv | 2022-08-01 | 2022-08-01 | 152,812 | — | $0 | 152,812 | SEC↗ |
| Knappertz Volker | EVP, Research and Developmen | A Award deriv | 2022-08-01 | 2022-08-01 | 256,892 | — | $0 | 256,892 | SEC↗ |
| Jayne David R.W. | Director | M Exercise deriv | 2022-05-18 | 2022-07-11 | 10,000 | — | $0 | 0 | SEC↗ |
| Jayne David R.W. | Director | M Exercise | 2022-05-18 | 2022-07-11 | 10,000 | $3.62 | $36.2K | 40,000 | SEC↗ |
| Hagan Joseph P | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 8,733 | — | $0 | 8,733 | SEC↗ |
| Hagan Joseph P | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 14,612 | — | $0 | 14,612 | SEC↗ |
| Balakrishnan Brinda | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 14,612 | — | $0 | 14,612 | SEC↗ |
| Balakrishnan Brinda | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 8,733 | — | $0 | 8,733 | SEC↗ |
| Leversage Jill | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 14,612 | — | $0 | 14,612 | SEC↗ |
| Leversage Jill | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 8,733 | — | $0 | 8,733 | SEC↗ |
| Jayne David R.W. | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 14,612 | — | $0 | 14,612 | SEC↗ |
| Jayne David R.W. | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 8,733 | — | $0 | 8,733 | SEC↗ |
| Walbert Timothy P | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 14,612 | — | $0 | 14,612 | SEC↗ |
| Walbert Timothy P | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 8,733 | — | $0 | 8,733 | SEC↗ |
| Billen Daniel | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 14,612 | — | $0 | 14,612 | SEC↗ |
| Billen Daniel | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 8,733 | — | $0 | 8,733 | SEC↗ |
| MacKay-Dunn R. Hector | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 14,612 | — | $0 | 14,612 | SEC↗ |
| MacKay-Dunn R. Hector | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 8,733 | — | $0 | 8,733 | SEC↗ |
| MILNE GEORGE M JR | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 8,733 | — | $0 | 8,733 | SEC↗ |
| MILNE GEORGE M JR | Director | A Award deriv | 2022-05-18 | 2022-05-20 | 14,612 | — | $0 | 14,612 | SEC↗ |
| MacKay-Dunn R. Hector | Director | P Buy | 2022-03-09 | 2022-03-11 | 5,000 | $11.00 | $55.0K | 11,000 | SEC↗ |
| MILNE GEORGE M JR | Director | P Buy | 2022-03-04 | 2022-03-08 | 5,000 | $10.82 | $54.1K | 50,000 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | A Award deriv | 2022-03-02 | 2022-03-04 | 106,838 | — | $0 | 106,838 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | A Award deriv | 2022-03-02 | 2022-03-04 | 62,448 | — | $0 | 62,448 | SEC↗ |
| Solomons Neil | Chief Medical Officer | A Award deriv | 2022-03-02 | 2022-03-04 | 72,856 | — | $0 | 72,856 | SEC↗ |
| Solomons Neil | Chief Medical Officer | A Award deriv | 2022-03-02 | 2022-03-04 | 124,644 | — | $0 | 124,644 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award deriv | 2022-03-02 | 2022-03-04 | 178,063 | — | $0 | 178,063 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award deriv | 2022-03-02 | 2022-03-04 | 104,080 | — | $0 | 104,080 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award deriv | 2022-03-02 | 2022-03-04 | 534,188 | — | $0 | 534,188 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award deriv | 2022-03-02 | 2022-03-04 | 312,240 | — | $0 | 312,240 | SEC↗ |
| Colao Massimilano | Chief Commercial Officer | A Award deriv | 2022-03-02 | 2022-03-04 | 178,063 | — | $0 | 178,063 | SEC↗ |
| Colao Massimilano | Chief Commercial Officer | A Award deriv | 2022-03-02 | 2022-03-04 | 104,080 | — | $0 | 104,080 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award deriv | 2022-03-02 | 2022-03-04 | 178,063 | — | $0 | 178,063 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award deriv | 2022-03-02 | 2022-03-04 | 104,080 | — | $0 | 104,080 | SEC↗ |
| Donley Matthew Maxwell | Ex VP, Intern'l Operations | A Award deriv | 2022-03-02 | 2022-03-04 | 178,063 | — | $0 | 178,063 | SEC↗ |
| Donley Matthew Maxwell | Ex VP, Intern'l Operations | A Award deriv | 2022-03-02 | 2022-03-04 | 104,080 | — | $0 | 104,080 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | A Award deriv | 2022-03-02 | 2022-03-04 | 106,838 | — | $0 | 106,838 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | A Award deriv | 2022-03-02 | 2022-03-04 | 62,448 | — | $0 | 62,448 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | A Award | 2022-03-02 | 2022-03-04 | 8,500 | — | $0 | 74,228 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | S Sale | 2022-03-02 | 2022-03-04 | 4,849 | $12.01 | $58.2K | 69,379 | SEC↗ |
| Solomons Neil | Chief Medical Officer | A Award | 2022-03-02 | 2022-03-04 | 8,500 | — | $0 | 95,799 | SEC↗ |
| Solomons Neil | Chief Medical Officer | S Sale | 2022-03-02 | 2022-03-04 | 4,846 | $12.01 | $58.2K | 90,953 | SEC↗ |
| Robertson Stephen P. | EVP, General Counsel | A Award | 2022-03-02 | 2022-03-04 | 8,500 | — | $0 | 11,682 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | S Sale | 2022-03-02 | 2022-03-04 | 9,068 | $12.01 | $108.9K | 32,967 | SEC↗ |
| Greenleaf Peter | Chief Executive Officer | A Award | 2022-03-02 | 2022-03-04 | 28,300 | — | $0 | 42,035 | SEC↗ |
| Colao Massimilano | Chief Commercial Officer | S Sale | 2022-03-02 | 2022-03-04 | 3,205 | $12.01 | $38.5K | 13,495 | SEC↗ |
| Colao Massimilano | Chief Commercial Officer | A Award | 2022-03-02 | 2022-03-04 | 8,500 | — | $0 | 16,700 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | A Award | 2022-03-02 | 2022-03-04 | 8,500 | — | $0 | 9,670 | SEC↗ |
| Miller Joseph M | Chief Financial Officer | S Sale | 2022-03-02 | 2022-03-04 | 3,060 | $12.01 | $36.8K | 6,610 | SEC↗ |
| Donley Matthew Maxwell | Ex VP, Intern'l Operations | S Sale | 2022-03-02 | 2022-03-04 | 3,052 | $12.01 | $36.7K | 16,224 | SEC↗ |
| Donley Matthew Maxwell | Ex VP, Intern'l Operations | A Award | 2022-03-02 | 2022-03-04 | 8,500 | — | $0 | 19,276 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2022-03-02 | 2022-03-04 | 4,849 | $12.01 | $58.2K | 59,512 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | A Award | 2022-03-02 | 2022-03-04 | 8,500 | — | $0 | 64,361 | SEC↗ |
| Hagan Joseph P | Director | M Exercise deriv | 2022-01-03 | 2022-01-04 | 40,000 | — | $0 | 10,000 | SEC↗ |
| Hagan Joseph P | Director | S Sale | 2022-01-03 | 2022-01-04 | 634 | $23.29 | $14.8K | 3,500 | SEC↗ |
| Hagan Joseph P | Director | S Sale | 2022-01-03 | 2022-01-04 | 39,366 | $22.58 | $888.9K | 4,134 | SEC↗ |
| Hagan Joseph P | Director | M Exercise | 2022-01-03 | 2022-01-04 | 40,000 | $5.08 | $203.2K | 43,500 | SEC↗ |
| Leversage Jill | Director | P Buy | 2021-12-13 | 2021-12-15 | 1,600 | $20.04 | $32.1K | 5,300 | SEC↗ |
| Solomons Neil | Chief Medical Officer | M Exercise deriv | 2021-11-11 | 2021-11-12 | 100,000 | — | $0 | 0 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise deriv | 2021-11-11 | 2021-11-12 | 29,000 | — | $0 | 27,900 | SEC↗ |
| Solomons Neil | Chief Medical Officer | S Sale | 2021-11-11 | 2021-11-12 | 100,000 | $28.89 | $2.89M | 87,299 | SEC↗ |
| Solomons Neil | Chief Medical Officer | M Exercise | 2021-11-11 | 2021-11-12 | 100,000 | $5.30 | $530.0K | 187,299 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-11-11 | 2021-11-12 | 29,000 | $28.82 | $835.8K | 66,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise | 2021-11-11 | 2021-11-12 | 29,000 | $18.38 | $533.0K | 95,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-11-11 | 2021-11-12 | 11,000 | $29.50 | $324.5K | 55,861 | SEC↗ |
| Solomons Neil | Chief Medical Officer | M Exercise deriv | 2021-11-10 | 2021-11-12 | 70,000 | — | $0 | 0 | SEC↗ |
| Solomons Neil | Chief Medical Officer | M Exercise deriv | 2021-11-10 | 2021-11-12 | 30,000 | — | $0 | 100,000 | SEC↗ |
| Solomons Neil | Chief Medical Officer | S Sale | 2021-11-10 | 2021-11-12 | 90,000 | $31.17 | $2.81M | 97,299 | SEC↗ |
| Solomons Neil | Chief Medical Officer | S Sale | 2021-11-10 | 2021-11-12 | 10,000 | $30.55 | $305.5K | 87,299 | SEC↗ |
| Solomons Neil | Chief Medical Officer | M Exercise | 2021-11-10 | 2021-11-12 | 70,000 | $6.06 | $424.2K | 157,299 | SEC↗ |
| Solomons Neil | Chief Medical Officer | M Exercise | 2021-11-10 | 2021-11-12 | 30,000 | $5.30 | $159.0K | 187,299 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-11-10 | 2021-11-12 | 50,000 | $31.26 | $1.56M | 76,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-11-10 | 2021-11-12 | 10,000 | $30.55 | $305.5K | 66,861 | SEC↗ |
| Solomons Neil | Chief Medical Officer | S Sale | 2021-11-09 | 2021-11-12 | 50,000 | $30.17 | $1.51M | 87,299 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-11-09 | 2021-11-12 | 50,000 | $30.17 | $1.51M | 126,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise deriv | 2021-11-01 | 2021-11-03 | 45,000 | — | $0 | 0 | SEC↗ |
| Solomons Neil | Chief Medical Officer | M Exercise deriv | 2021-11-01 | 2021-11-03 | 45,000 | — | $0 | 130,000 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise | 2021-11-01 | 2021-11-03 | 45,000 | $3.20 | $144.0K | 221,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-11-01 | 2021-11-03 | 45,000 | $31.64 | $1.42M | 176,861 | SEC↗ |
| Solomons Neil | Chief Medical Officer | S Sale | 2021-11-01 | 2021-11-03 | 45,000 | $31.64 | $1.42M | 137,299 | SEC↗ |
| Solomons Neil | Chief Medical Officer | M Exercise | 2021-11-01 | 2021-11-03 | 45,000 | $5.30 | $238.5K | 182,299 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | M Exercise deriv | 2021-10-25 | 2021-10-26 | 95,000 | — | $0 | 3,864 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | S Sale | 2021-10-25 | 2021-10-26 | 130,000 | $29.75 | $3.87M | 65,728 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | M Exercise | 2021-10-25 | 2021-10-26 | 95,000 | $3.20 | $304.0K | 195,728 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise deriv | 2021-09-21 | 2021-09-22 | 7,500 | — | $0 | 0 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise deriv | 2021-09-21 | 2021-09-22 | 70,000 | — | $0 | 0 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise deriv | 2021-09-21 | 2021-09-22 | 10,000 | — | $0 | 56,900 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | M Exercise deriv | 2021-09-21 | 2021-09-22 | 16,000 | — | $0 | 0 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | M Exercise deriv | 2021-09-21 | 2021-09-22 | 11,136 | — | $0 | 98,864 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise | 2021-09-21 | 2021-09-22 | 10,000 | $18.38 | $183.8K | 264,361 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-09-21 | 2021-09-22 | 87,500 | $24.02 | $2.10M | 176,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise | 2021-09-21 | 2021-09-22 | 7,500 | $5.30 | $39.8K | 184,361 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise | 2021-09-21 | 2021-09-22 | 70,000 | $6.06 | $424.2K | 254,361 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | M Exercise | 2021-09-21 | 2021-09-22 | 16,000 | $2.63 | $42.1K | 122,092 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | S Sale | 2021-09-21 | 2021-09-22 | 5,364 | $23.66 | $126.9K | 100,728 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | M Exercise | 2021-09-21 | 2021-09-22 | 11,136 | $3.20 | $35.6K | 133,228 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | S Sale | 2021-09-21 | 2021-09-22 | 27,136 | $24.05 | $652.6K | 106,092 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise deriv | 2021-09-20 | 2021-09-22 | 28,500 | $5.30 | $151.1K | 7,500 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-09-20 | 2021-09-22 | 16,000 | $21.60 | $345.6K | 176,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise | 2021-09-20 | 2021-09-22 | 28,500 | $5.30 | $151.1K | 205,361 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-09-20 | 2021-09-22 | 12,500 | $21.71 | $271.4K | 192,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise deriv | 2021-09-14 | 2021-09-14 | 45,000 | — | $0 | 80,000 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise deriv | 2021-09-14 | 2021-09-14 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise deriv | 2021-09-14 | 2021-09-16 | 44,000 | — | $0 | 36,000 | SEC↗ |
| Huizinga Robert Bindert | EVP of Research | S Sale | 2021-09-14 | 2021-09-14 | 22,500 | $21.75 | $489.4K | 106,092 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise | 2021-09-14 | 2021-09-14 | 45,000 | $3.20 | $144.0K | 266,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise | 2021-09-14 | 2021-09-14 | 45,000 | $5.30 | $238.5K | 221,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-09-14 | 2021-09-14 | 90,000 | $21.19 | $1.91M | 176,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-09-14 | 2021-09-16 | 14,000 | $21.73 | $304.2K | 206,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise | 2021-09-14 | 2021-09-16 | 44,000 | $5.30 | $233.2K | 220,861 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | S Sale | 2021-09-14 | 2021-09-16 | 30,000 | $21.80 | $654.0K | 176,861 | SEC↗ |
| Solomons Neil | Chief Medical Officer | M Exercise deriv | 2021-09-13 | 2021-09-14 | 150,000 | — | $0 | 2,000 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise deriv | 2021-09-13 | 2021-09-14 | 25,000 | — | $0 | 125,000 | SEC↗ |
| Solomons Neil | Chief Medical Officer | M Exercise | 2021-09-13 | 2021-09-14 | 150,000 | $3.20 | $480.0K | 287,299 | SEC↗ |
| Martin Michael Robert | Chief Business Officer | M Exercise | 2021-09-13 | 2021-09-14 | 25,000 | $5.30 | $132.5K | 201,861 | SEC↗ |